Inactive Instrument

Insiders Biosante Pharmaceuticals Inc Nasdaq

Equities

US09065V3024

End-of-day quote Nasdaq Other stock markets
- ^USD	-

07-02	ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets	MT
07-02	ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ani Pharmaceuticals Insider Sold Shares Worth $1,817,663, According to a Recent SEC Filing	06-21	MT
Ani Pharmaceuticals Insider Sold Shares Worth $317,900, According to a Recent SEC Filing	06-06	MT
ANI Pharmaceuticals Insider Sold Shares Worth $1,288,200, According to a Recent SEC Filing	06-05	MT
Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing	05-21	MT
Ani Pharmaceuticals Insider Sold Shares Worth $1,101,821, According to a Recent SEC Filing	05-16	MT
Ani Pharmaceuticals Insider Sold Shares Worth $1,332,400, According to a Recent SEC Filing	05-03	MT
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	04-17	MT
Ani Pharmaceuticals Insider Sold Shares Worth $1,345,000, According to a Recent SEC Filing	04-03	MT
Ani Pharmaceuticals Insider Sold Shares Worth $671,700, According to a Recent SEC Filing	03-12	MT
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing	03-08	MT
Ani Pharmaceuticals Insider Sold Shares Worth $456,400, According to a Recent SEC Filing	03-06	MT
Ani Pharmaceuticals Insider Sold Shares Worth $330,000, According to a Recent SEC Filing	03-06	MT
Ani Pharmaceuticals Insider Sold Shares Worth $1,416,466, According to a Recent SEC Filing	01-23	MT
Ani Pharmaceuticals Insider Sold Shares Worth $1,370,305, According to a Recent SEC Filing	01-19	MT
Ani Pharmaceuticals Insider Sold Shares Worth $2,627,250, According to a Recent SEC Filing	12-19	MT
Ani Pharmaceuticals Insider Sold Shares Worth $663,000, According to a Recent SEC Filing	11-21	MT
ANI Pharmaceuticals Insider Sold Shares Worth $1,918,080, According to a Recent SEC Filing	11-17	MT
ANI Pharmaceuticals Insider Sold Shares Worth $141,090, According to a Recent SEC Filing	11-17	MT
Ani Pharmaceuticals Insider Sold Shares Worth $157,410, According to a Recent SEC Filing	11-13	MT
Ani Pharmaceuticals Insider Sold Shares Worth $1,443,869, According to a Recent SEC Filing	19/10/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Biosante Pharmaceuticals Inc Nasdaq

Equities

US09065V3024

Insiders

Filters